A recent study, published in the journal JAMA Network Open, revealed that the AI chatbot ChatGPT outperformed a group of doctors in diagnosing medical conditions based on case histories. The doctors, who had access to both conventional medical resources and ChatGPT, performed only slightly better than those who did not use the chatbot. The study highlighted two key findings: first, doctors often remained convinced of their initial diagnosis even when ChatGPT suggested a different and potentially more accurate diagnosis. Second, the doctors struggled to fully utilise ChatGPT's capabilities, failing to take advantage of its ability to process complex medical information and provide comprehensive diagnostic analyses. This suggests that while AI chatbots hold significant potential as tools for diagnosis, further research is necessary to understand how to effectively integrate them into medical practice and overcome the challenges of doctor-AI collaboration.

Briefing Doc: A.I. Chatbots vs. Doctors in Diagnosing Illness

AI Chatbots in Medicine: An FAQ

MY Times

Original Study

This episode highlights the use of artificial intelligence in breast cancer screening, focusing on the software developed by Volpara Health. Volpara's AI technology improves mammogram image quality, assesses breast density, and assists radiologists in detecting abnormalities. The software also provides patients a clearer understanding of their results through visual representations and educational resources. The episode emphasizes the importance of integrating AI ethically into healthcare to improve patient outcomes and enhance the patient experience.

Volpara Health Website

Briefing Doc: AI-Powered Breast Cancer Screening with Volpara

FAQ: Revolutionising Breast Cancer Screening with AI

This episode explores the changing healthcare landscape in the UK and Europe, highlighting the challenges hospitals and medical technology (medtech) companies face. The paper identifies four critical considerations for MedTech companies operating in Europe: the need to deliver value innovation beyond clinical features, to partner with customers beyond the product, to solve prevalent problems with scalable solutions, and to use technology to support models more patient-centric. The paper argues that by embracing these considerations, MedTech companies can position themselves as strategic partners to European healthcare providers and address the region's most pressing challenges.

The episode is based on the ZS whitepaper Transforming Global Healthcare Together: Medtech’s Role in empowering providers in Europe

Briefing Document PDF

Episode FAQ Document PDF